Freenome, Inc. Common stock FRNM
$16.32
+4.35%
at last close
Market Cap$1.75 billion
P/E Ratio—
Div Yield—
Volume813.6K
52-Week Range
$9.97$17.50
Analyst Ratings
- Consensus
- Buy — 5 Buy · 0 Hold · 0 Sell (5 analysts)
- Avg. Price Target
- $18.00 (+10.3% upside)
Key Stats
- Today's Range
- $15.48 – $16.35
- 50-Day Range
- $9.97 – $17.50
- 52-Week Range
- $9.97 – $17.50
- Volume
- 814K shs
- Average Volume
- 865K shs
- Market Cap
- $1.75 billion
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.41%
- Days to Cover
- 1.00
About Freenome, Inc. Common stock
Freenome Inc is a development-stage, early cancer detection company developing blood-based screening tests leveraging a proprietary artificial intelligence/machine learning multiomics technology platform to transform multi-cancer and ultimately multi-disease detection. It is developing a range of blood-based cancer screening tests.
Related Stocks
Compare head-to-head: FRNM vs NTRA·FRNM vs DGX·FRNM vs CAI·FRNM vs GRAL
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.